New Alzheimer's drug hailed as 'beginning of the end' in search for treatment | The Wiltshire Gazette and Herald
Lecanemab was found to slow decline in patients’ memory and thinking.
Stay updated with breaking news from Bart De Strooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lecanemab was found to slow decline in patients’ memory and thinking.
Experts hailed full data Wednesday showing a new drug can slow cognitive decline in Alzheimer's patients, but warned improvements were comparatively small and
Lecanemab was found to slow decline in patients’ memory and thinking.
Experts have hailed the “beginning of the end” in the search for effective Alzheimer’s treatments after a new drug reduced memory decline…
Phase three clinical trials have shown that lecanemab, made by Tokyo-based Eisai, can halt the declines in memory and thinking among patients in the earliest stages.